Cargando…
Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
The emergence of new resistance mechanisms, the failure of classical antibiotics in clinic, the decrease in the development of antibiotics in the industry are all challenges that lead us to consider new strategies for the treatment of infectious diseases. Indeed, in recent years controversy has inte...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579884/ https://www.ncbi.nlm.nih.gov/pubmed/31245302 http://dx.doi.org/10.3389/fcimb.2019.00193 |